Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference

Leukemia & Lymphoma
Martin DreylingEuropean MCL Network

Abstract

Mantle cell lymphoma (MCL) is a distinct subtype of malignant lymphoma which is characterized by the chromosomal translocation t(11;14)(q13;q32), resulting in constitutional overexpression of cyclin D1 and cell cycle dysregulation in virtually all cases. Clinically, MCL shows an aggressive clinical course with a continuous relapse pattern and a median survival of only 3-5 years. However, recently a subset of 15% long-term survivors has been identified with a rather indolent clinical course, even after conventional treatment strategies only. Advanced stage disease is usually apparent already at first clinical manifestation; thus, conventional chemotherapy is only palliative, and the median duration of remissions is only 1-2 years. Emerging strategies including proteasome inhibitors, immune modulatory drugs (IMiDs), mTOR inhibitors, and others are based on the dysregulated control of cell cycle machinery and impaired apoptotic pathways. Monotherapy of these compounds achieves efficacy comparable to conventional chemotherapy in relapsed MCL, and combination strategies are currently being investigated in numerous trials; however, their introduction into clinical practice and current treatment algorithms remain a challenge. In 2000 ...Continue Reading

References

Jan 1, 1997·Critical Reviews in Immunology·M L Bireland, J G Monroe
Mar 3, 2004·Molecular Interventions·Thomas T SuDavid J Rawlings
Aug 27, 2005·Blood·Kai FuUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Feb 9, 2007·Leukemia·V H J van der VeldenUNKNOWN European Study Group on MRD detection in ALL (ESG-MRD-ALL)
Feb 14, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Itziar SalaverriaElias Campo
Mar 31, 2007·Histopathology·A-V DecouvelaereC Dumontet
Oct 2, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F MorschhauserM Dreyling
Oct 27, 2007·Blood·Eva HosterUNKNOWN European Mantle Cell Lymphoma Network
Mar 6, 2008·British Journal of Haematology·Christian BritschgiMario P Tschan
Jul 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter H WiernikThomas M Habermann
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Sue RobinsonBruce D Cheson
Aug 30, 2008·The International Journal of Biochemistry & Cell Biology·Capucine FleurielDominique Leprince
Sep 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Georg LenzLouis M Staudt
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter MartinJohn P Leonard
Aug 12, 2009·Journal of Hematopathology
Sep 15, 2009·PloS One·Jose I Martin-SuberoReiner Siebert
Oct 14, 2009·Bulletin du cancer·Vanessa Dehennaut, Dominique Leprince
Oct 30, 2009·Leukemia & Lymphoma·Oliver WeigertMartin Dreyling
Dec 17, 2009·Hematology·Martin DreylingUNKNOWN European MCL Network
Feb 4, 2010·Cancer Research·Verònica FernàndezElías Campo
Feb 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M DreylingE Zucca

❮ Previous
Next ❯

Citations

Jul 17, 2012·Transplantation·Pierre PeterlinSteven Le Gouill
Jul 20, 2013·Leukemia & Lymphoma·Francesco ZajaPier Luigi Zinzani
Nov 2, 2012·Leukemia & Lymphoma·Karem Humala, Anas Younes
Jun 13, 2012·Best Practice & Research. Clinical Haematology·Richa Dawar, Francisco Hernandez-Ilizaliturri
Apr 24, 2012·Hematology/oncology Clinics of North America·Jasmine Zain
Jul 26, 2011·Seminars in Hematology·Stéphanie HarelOlivier Hermine
Mar 23, 2011·Seminars in Oncology·Erika RamsdaleSonali M Smith
Sep 22, 2012·British Journal of Haematology·P McKayUNKNOWN British Committee for Standards in Haematology
Jan 20, 2012·Annals of Laboratory Medicine·Yoonmi SeokKyung-A Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.